Expertise in NGS-based LDTs and Related Diagnostics

Octyne Inc has extensive experience in diagnostic and genetic test commercialization. We’ve launched more than 300 diagnostic tests as LDTs in the the clinical diagnostic space using next generation sequencing (NGS) technologies.

We consult across the development process, from assay design to commercialization + branding of single gene & multi-gene panels, exome and genomes in various disease categories that include, oncology, prenatal, neonatal, neurology, cardiac and general genetics. All processes have been set in CLIA an CAP accredited environments.


LDT Consulting Opportunities

Have a background in NGS, LDTs, CLIA/CAP and/or Regulatory? Contact Octyne to explore exciting consulting ventures for LDT development and regulatory phases. Submit your application today!

Apply Today